Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).

被引:0
|
作者
Assadi, Majid
Manafi-Farid, Reyhaneh
Jafai, Esmail
Keshavarz, Ahmad
Divband, GhasemAli
Moradi, Mohammad Mobin
Adinehpour, Zohreh
Samimi, Rezvan
Dadgar, Habibollah
Mayer, Benjamin
Prasad, Vikas
机构
[1] Bushehr Univ Med Sci, Bushehr, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
[3] Persian Gulf Univ, Bushehr, Iran
[4] Khatam PET CT Ctr, Tehran, Iran
[5] Shahid Beheshti Univ, Tehran, Iran
[6] Razavi Hosp, Canc Res Ctr, Mashhad, Iran
[7] Univ Ulm, Ulm, Germany
[8] Univ Hosp Ulm, Ulm, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
200
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA
    Assadi, Majid
    Manafi-Farid, Reyhaneh
    Jafari, Esmail
    Keshavarz, Ahmad
    Divband, GhasemAli
    Moradi, Mohammad Mobin
    Adinehpour, Zohreh
    Samimi, Rezvan
    Dadgar, Habibollah
    Jokar, Narges
    Mayer, Benjamin
    Prasad, Vikas
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Impact of 68Ga-PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
    Altavilla, Amelia
    Caroli, Paola
    Giunta, Emilio Francesco
    Scarpi, Emanuela
    Rossetti, Virginia
    Casadei, Chiara
    Lolli, Cristian
    Schepisi, Giuseppe
    Bleve, Sara
    Cursano, Maria Concetta
    Gasperoni, Lorenzo
    Matteucci, Federica
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Jensen, A.
    Karunaratna, N.
    Wong, S.
    Shapiro, J.
    Weickhardt, A.
    Spain, L.
    Azad, A. A.
    Kwan, E.
    Muthusamy, A.
    Torres, J.
    Parente, P.
    Francis, P.
    Parnis, F. X.
    Goh, J.
    Gibbs, P.
    Tran, B.
    Anton, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1329 - S1330
  • [4] FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Cho, Steve Y.
    Kim, Chun Ki
    Cline, Kathryn
    Emmenegger, Urban
    Hotte, Sebastien J.
    Pond, Gregory Russell
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Karunaratna, Nathasha
    Jensen, Andrew
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Spain, Lavinia
    Azad, Arun
    Kwan, Edmond M.
    Muthusamy, Arun
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Gibbs, Peter
    Tran, Ben
    Anton, Angelyn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 58 - 58
  • [6] Imaging of Metastatic Castration-Resistant Prostate Cancer - Comparison of 68Ga-RM2 and 68Ga-PSMA PET/CT
    Heuschkel, M.
    Kurth, J.
    Hakenberg, O. W.
    Schwarzenboeck, S. M.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S151 - S151
  • [7] Castration-Resistant Prostate Cancer Patterns of Metastasis Evaluated by 68Ga-PSMA PET/CT
    Silva, M.
    Silva, R.
    Lapa, P.
    Costa, G.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S721 - S721
  • [8] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [9] Correlating 68Ga-PSMA PET/CT Imaging Features with PSA Variation for Castration-Resistant Prostate Cancer Patients
    Eduardo, R.
    Badel, J.
    Sarrut, D.
    Paquet, E.
    Giraudet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S720 - S720
  • [10] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Heinzel, Alexander
    Boghos, Dima
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1054 - 1062